Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 10 03:47PM ET
4.15
Dollar change
+0.10
Percentage change
2.47
%
Index- P/E- EPS (ttm)-3.03 Insider Own62.91% Shs Outstand1.09M Perf Week74.37%
Market Cap4.54M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float0.41M Perf Month26.91%
Income-14.73M PEG- EPS next Q- Inst Own1.53% Short Float19.23% Perf Quarter-7.78%
Sales1.31M P/S3.47 EPS this Y- Inst Trans200.79% Short Ratio0.06 Perf Half Y-39.86%
Book/sh-13.34 P/B- EPS next Y- ROA-59.51% Short Interest0.08M Perf Year-32.16%
Cash/sh0.93 P/C4.45 EPS next 5Y- ROE-132.59% 52W Range2.11 - 21.60 Perf YTD-42.72%
Dividend Est.- P/FCF- EPS past 5Y-8.00% ROI-204.11% 52W High-80.79% Beta0.21
Dividend TTM- Quick Ratio0.11 Sales past 5Y-4.02% Gross Margin18.63% 52W Low96.68% ATR (14)0.66
Dividend Ex-Date- Current Ratio0.11 EPS Y/Y TTM-234.05% Oper. Margin-290.06% RSI (14)65.56 Volatility24.54% 14.48%
Employees5 Debt/Eq1.61 Sales Y/Y TTM6.36% Profit Margin-1125.62% Recom- Target Price-
Option/ShortNo / Yes LT Debt/Eq0.34 EPS Q/Q-1220.13% Payout- Rel Volume0.15 Prev Close4.05
Sales Surprise- EPS Surprise- Sales Q/Q4.19% Earnings- Avg Volume1.42M Price4.15
SMA2040.11% SMA5034.60% SMA200-12.44% Trades Volume211,164 Change2.47%
Nov-21-24 09:00AM
Nov-18-24 09:00AM
Oct-31-24 09:00AM
Oct-25-24 09:00AM
08:31AM
09:00AM Loading…
Oct-24-24 09:00AM
Oct-09-24 09:00AM
Aug-14-24 08:00AM
07:30AM
Jul-31-24 08:00AM
Jul-18-24 09:00AM
Jun-21-24 07:30AM
Jun-20-24 08:30AM
Jun-04-24 11:00AM
08:55AM
07:28AM Loading…
07:28AM
Jun-03-24 02:53PM
May-24-24 05:00PM
May-21-24 08:30AM
Apr-22-24 09:00AM
Apr-16-24 09:52AM
Mar-28-24 09:00AM
Dec-18-23 09:00AM
Oct-18-23 09:00AM
Oct-04-23 09:00AM
Sep-13-23 09:15AM
Sep-05-23 08:00AM
Aug-30-23 10:45AM
09:00AM
Aug-21-23 09:00AM
09:00AM Loading…
Jul-24-23 09:00AM
Jul-19-23 09:00AM
Jul-10-23 09:00AM
Apr-27-23 09:00AM
Apr-17-23 09:00AM
Apr-11-23 09:00AM
Mar-03-23 09:00AM
Feb-13-23 09:00AM
Jan-17-23 09:00AM
Jan-11-23 09:00AM
Jan-03-23 09:00AM
Dec-14-22 09:00AM
Dec-12-22 09:00AM
Avalon GloboCare Corp. is a clinical-stage biotechnology company, which engages in the development of immune effector cell therapy and laboratory services. It operates through the Real Property Operating and Medical Related Consulting Services segments. The Real Property Operating segment includes property management fees, property insurance, real estate taxes, depreciation, repairs and maintenance fees, utilities and other expenses related to rental properties. The Medical Related Consulting segment relates to labor and related benefits, travel expenses, and related to consulting services. The company was founded on July 28, 2014 and is headquartered in Freehold, NJ.